Compare GDV & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GDV | LMAT |
|---|---|---|
| Founded | 2003 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | N/A | 2006 |
| Metric | GDV | LMAT |
|---|---|---|
| Price | $30.36 | $81.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $105.80 |
| AVG Volume (30 Days) | 87.9K | ★ 348.0K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 5.81% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | $56.92 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $26.14 | $78.65 |
| 52 Week High | $30.43 | $118.01 |
| Indicator | GDV | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 61.82 | 31.43 |
| Support Level | $28.67 | N/A |
| Resistance Level | N/A | $89.00 |
| Average True Range (ATR) | 0.32 | 4.11 |
| MACD | 0.03 | -2.06 |
| Stochastic Oscillator | 78.76 | 7.86 |
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, including Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services, and others.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.